Literature DB >> 22772969

Examination of the relationship between chromosome abnormality in pituitary adenomas and tumor invasiveness by normal karyotype analysis and interphase fluorescence staining.

Heng Gao1, Qiping Wang, Sirong Wu, Guozhen Hui.   

Abstract

To study the potential relationship between chromosome abnormality and tumor invasiveness in pituitary adenomas. To use conventional R-band cytogenetic karyotype analysis and interphase fluorescence in situ hybridization using centromeric probe of chromosomes 8, 9, and 11 to detect chromosome abnormality in 30 cases of pituitary adenoma. All chromosomes except chromosomes 4, 16, and Y show significant variation between invasive and noninvasive pituitary adenomas. Chromosomes 8 and 12 display some type of numeric alteration in all endocrine subtypes of pituitary adenoma. Numeric alterations in chromosomes 9, 11, and 19 are more frequently detected in invasive pituitary adenomas compared with noninvasive tumors. Numeric alterations in chromosomes are common in all endocrine subtype pituitary adenomas. Furthermore, chromosome numbers are significantly different in invasive and noninvasive pituitary adenomas. On the basis of our study and literature review, we conclude that while chromosomes 8 and 12 may play important roles in the occurrence of pituitary adenomas, chromosomes 9, 11, and 19 may be specifically associated with invasiveness.

Entities:  

Mesh:

Year:  2012        PMID: 22772969     DOI: 10.1007/s12032-012-0296-7

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  11 in total

1.  Simple numerical chromosome aberrations characterize pituitary adenomas.

Authors:  J B Larsen; H D Schrøder; A G Sørensen; P Bjerre; S Heim
Journal:  Cancer Genet Cytogenet       Date:  1999-10-15

Review 2.  Molecular cytogenetics of pituitary adenomas, assessed by FISH technique.

Authors:  George Kontogeorgos
Journal:  Front Horm Res       Date:  2004       Impact factor: 2.606

3.  Identification of the human pituitary tumor transforming gene (hPTTG) family: molecular structure, expression, and chromosomal localization.

Authors:  L Chen; R Puri; E J Lefkowitz; S S Kakar
Journal:  Gene       Date:  2000-05-02       Impact factor: 3.688

4.  Monosomy of chromosome 11 in pituitary adenoma in a patient with familial multiple endocrine neoplasia type 1.

Authors:  G Kontogeorgos; N Kapranos; I Tzavara; N Thalassinos; D Rologis
Journal:  Clin Endocrinol (Oxf)       Date:  2001-01       Impact factor: 3.478

5.  Chromosomal characteristics of human pituitary adenomas.

Authors:  J Mark
Journal:  Acta Neuropathol       Date:  1971       Impact factor: 17.088

6.  Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker.

Authors:  A S Bates; W E Farrell; E J Bicknell; A M McNicol; A J Talbot; J C Broome; C W Perrett; R V Thakker; R N Clayton
Journal:  J Clin Endocrinol Metab       Date:  1997-03       Impact factor: 5.958

7.  Infrequent mutations of p27Kip1 gene and trisomy 12 in a subset of human pituitary adenomas.

Authors:  C Tanaka; K Yoshimoto; P Yang; T Kimura; S Yamada; M Moritani; T Sano; M Itakura
Journal:  J Clin Endocrinol Metab       Date:  1997-09       Impact factor: 5.958

8.  Cytogenetic study of pituitary adenomas.

Authors:  D Bettio; N Rizzi; D Giardino; L Persani; F Pecori-Giraldi; M Losa; L Larizza
Journal:  Cancer Genet Cytogenet       Date:  1997-10-15

9.  Non-random trisomies of chromosomes 5, 8 and 12 in the prolactinoma sub-type of pituitary adenomas: conventional cytogenetics and interphase FISH study.

Authors:  P Finelli; D Giardino; N Rizzi; S Buiatiotis; T Virduci; A Franzin; M Losa; L Larizza
Journal:  Int J Cancer       Date:  2000-05-01       Impact factor: 7.396

10.  Analysis of loss of heterozygosity on chromosome 11 and infrequent inactivation of the MEN1 gene in sporadic pituitary adenomas.

Authors:  C Tanaka; T Kimura; P Yang; M Moritani; T Yamaoka; S Yamada; T Sano; K Yoshimoto; M Itakura
Journal:  J Clin Endocrinol Metab       Date:  1998-08       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.